Population Pharmacokinetics of Bedaquiline (TMC207), a Novel Antituberculosis Drug

類似資料

• Randomized Pilot Trial of Eight Weeks of Bedaquiline (TMC207) Treatment for Multidrug-Resistant Tuberculosis: Long-Term Outcome, Tolerability, and Effect on Emergence of Drug Resistance
  著者:: Diacon, A. H., 等
  出版事項: (2012)
• Prevention of Drug Carryover Effects in Studies Assessing Antimycobacterial Efficacy of TMC207
  著者:: Lounis, Nacer, 等
  出版事項: (2008)
• Safety, tolerability, and pharmacokinetic interactions of the antituberculous agent TMC207 (bedaquiline) with efavirenz in healthy volunteers: AIDS Clinical Trials Group study A5267
  著者:: Dooley, Kelly E, 等
  出版事項: (2012)
• A Review of the Evidence for Using Bedaquiline (TMC207) to Treat Multi-Drug Resistant Tuberculosis
  著者:: Fox, Gregory J., 等
  出版事項: (2013)
• Early Bactericidal Activity and Pharmacokinetics of the Diarylquinoline TMC207 in Treatment of Pulmonary Tuberculosis
  著者:: Rustomjee, R., 等
  出版事項: (2008)